Abstract:Type 1 Diabetes (T1D) is regarded as an autoimmune disease characterized by insulin deficiency resulting from destruction of pancreatic β-cells. The incidence rates of T1D have increased worldwide. Over the past decades, progress has been made in understanding the complexity of the immune response and its role in T1D pathogenesis, however, the trigger of T1D autoimmunity remains unclear. The increasing incidence rates, immigrant studies, and twin studies suggest that environmental factors play an important role and the trigger cannot simply be explained by genetic predisposition. Several research initiatives have identified environmental factors that potentially contribute to the onset of T1D autoimmunity and the progression of disease in children/young adults. More recently, the interplay between gut microbiota and the immune system has been implicated as an important factor in T1D pathogenesis. Although results often vary between studies, broad compositional and diversity patterns have emerged from both longitudinal and cross-sectional human studies. T1D patients have a less diverse gut microbiota, an increased prevalence of Bacteriodetes taxa and an aberrant metabolomic profile compared to healthy controls. In this comprehensive review, we present the data obtained from both animal and human studies focusing on the large longitudinal human studies. These studies are particularly valuable in elucidating the environmental factors that lead to aberrant gut microbiota composition and potentially contribute to T1D. We also discuss how environmental factors, such as birth mode, diet, and antibiotic use modulate gut microbiota and how this potentially contributes to T1D. In the final section, we focus on existing recent literature on microbiota-produced metabolites, proteins, and gut virome function as potential protectants or triggers of T1D onset. Overall, current results indicate that higher levels of diversity along with the presence of beneficial microbes and the resulting microbial-produced metabolites can act as protectors against T1D onset. However, the specifics of the interplay between host and microbes are yet to be discovered.

The Role of Epigenetics in Type 1 Diabetes

Implication of epigenetic factors in the pathogenesis of type 1 diabetes

Beyond Genetics: What Causes Type 1 Diabetes

Molecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review

Gene-environment interaction in the pathophysiology of type 1 diabetes

Reading between the (Genetic) Lines: How Epigenetics is Unlocking Novel Therapies for Type 1 Diabetes

Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem

Role of Epigenetics in the Pathogenesis,prevention and Treatment of Type 2 Diabetes

Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

Roles of Epigenetic Modifications in the Differentiation and Function of Pancreatic β-Cells

The Pathogenesis of Type 1 Diabetes

The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis

Cracking the type 1 diabetes code: Genes, microbes, immunity, and the early life environment

Advances in Knowledge of Candidate Genes Acting at the Beta-Cell Level in the Pathogenesis of T1DM.

Research Progress in the Regulation of Epigenetics on Pancreatic Β Cell Function

Gut Microbiome in Type 1 Diabetes: A Comprehensive Review

Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes

Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes

DNA methylation links genetics, fetal environment, and an unhealthy lifestyle to the development of type 2 diabetes

Environmental Factors Associated With Type 1 Diabetes